Search Results

2 results found

Core Policies | CSL

CSL's Board requires that our codes and policies are adhered to by all relevant parties and are reviewed and updated on a regular basis.

https://www.csl.com/we-are-csl/corporate-governance/core-policies
European Commission Approves CSL's ANDEMBRY® (garadacimab) for the Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) - Feb 13, 2025

Patients should inform their doctor if they are taking any other medicines, including any medicines, vitamins or supplements that you buy without a prescription from your pharmacy, supermarket or health food shop.

https://newsroom.csl.com/2025-02-13-European-Commission-Approves-CSLs-ANDEMBRY-R-garadacimab-for-the-Prevention-of-Recurrent-Attacks-of-Hereditary-Angioedema-HAE